Evidence map›Paper›PMID 30011875›Full record

ArticleInternational journal of molecular sciences2018

Mucins and Truncated

Ricardo Coelho, Lara Marcos-Silva, Nuno Mendes, Daniela Pereira, Catarina Brito, Francis Jacob, Catharina Steentoft, Ulla Mandel, Henrik Clausen, Leonor David and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Seminal Plasma Glycoproteins as Potential Ligands of Lectins Engaged in Immunity Regulation.International journal of environmental research and public health · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Cosmc overexpression enhances malignancies in human colon cancer.Journal of cellular and molecular medicine · 2020
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Ricardo CoelhoInstituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4099-002 Porto, Portugal. rjcoelho@ipatimup.pt.
Lara Marcos-SilvaInstituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4099-002 Porto, Portugal. laras@ipatimup.pt.ORCID 0000-0003-0212-8078
Nuno MendesInstituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4099-002 Porto, Portugal. nmendes@ipatimup.pt.
Daniela PereiraInstituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4099-002 Porto, Portugal. danismpereira@gmail.com.
Catarina BritoInstituto de Biologia Experimental e Tecnológica (iBET), 2780-901 Oeiras, Portugal. anabrito@ibet.pt.ORCID 0000-0002-8926-279X
Francis JacobGlyco-Oncology, Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031 Basel, Switzerland. francis.jacob@unibas.ch.ORCID 0000-0002-0446-1942
Catharina SteentoftCopenhagen Center for Glycomics, Department of Odontology, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark. steentoft@sund.ku.dk.ORCID 0000-0002-1424-6736
Ulla MandelCopenhagen Center for Glycomics, Department of Odontology, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark. ulma@sund.ku.dk.
Henrik ClausenCopenhagen Center for Glycomics, Department of Odontology, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark. hclau@sund.ku.dk.ORCID 0000-0002-0915-5055
Leonor DavidInstituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4099-002 Porto, Portugal. ldavid@ipatimup.pt.ORCID 0000-0003-4207-9258
Sara RicardoInstituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4099-002 Porto, Portugal. sricardo@ipatimup.pt.ORCID 0000-0003-4091-2226
Universidade do Porto · PTUniversity of Copenhagen · DKInstituto de Biologia Experimental e Tecnológica · PTUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optimal research results rely on the selection of cellular models capable of recapitulating the characteristics of primary tumours from which they originate. The expression of mucins (MUC16 and MUC1) and truncated

Indexed as

AnimalsBiomarkers, TumorCA-125 AntigenCell Line, TumorCystadenocarcinoma, SerousFemaleGene Expression ProfilingGlycosylationHumansMembrane ProteinsMice, NudeMolecular ChaperonesMucin-1Ovarian NeoplasmsPhenotypePolysaccharidesBiomarkers, TumorC1GALT1C1 protein, humanCA-125 AntigenMembrane ProteinsMolecular ChaperonesMUC16 protein, humanMUC1 protein, humanMucin-1PolysaccharidesCOSMCMUC1MUC16ovarian cancer cell linesserous ovarian carcinomastruncated O-glycans

Identifiers

PMID30011875
PMCPMC6073732
OpenAlexW2884610759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.